Francois Michelon

Revision as of 04:18, 29 April 2020 by Testudine (talk | contribs) (Created page with "{{Infobox Person | name = Francois Michelon | image = Francois Michelon.jpg | alt = | caption = | birth_name = François Michelon | birth...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Francois Michelon is a healthcare technology professional[1] who currently serves as the CEO and Board Chairman of ENDRA Life Sciences (Nasdaq: NDRA). ENDRA Life Sciences is a company that specializes in the early detection of liver diseases using Thermo Acoustic Enhanced Ultrasound (TAEU) technology.[2]

Francois Michelon
Francois Michelon.jpg
Born
United States
Occupation Businessman
Contact LinkedIn

Early Life and Education

Michelon obtained a Bachelor of Arts degree (BA) in Economics at the University of Chicago. Afterwards, he went on to obtain a Master of Business Administration degree (MBA) at Carnegie Mellon University in Pittsburgh, Pennsylvania. Michelon also obtained a Six Sigma Black Belt in Business Process Improvement.[3]

Career

Between 1997 and 2004, Michelon started his career by taking on global marketing, e-business, and six sigma roles at GE Health (NYSE: GE), a provider of medical technology specializing in health diagnosis, monitoring, and treatment.[4]

Michelon is the current CEO and Board Chairman of ENDRA Life Sciences, a position that he took on in 2015.[5][6] Additionally, he has worked at other companies such as Smith and Nephew Advanced Surgical Devices and Biomet 3i before joining ENDRA Life Sciences.[7][8]

References

  1. ^ ENDRA Life Sciences Inc. The Wall Street Journal.
  2. ^ LinkedIn.
  3. ^ LinkedIn.
  4. ^ LinkedIn.
  5. ^ Francois Michelon biography. Wallmine.
  6. ^ https://www.ptcommunity.com/wire/top-companies-watch-fight-against-breast-cancer-2020 The Top Companies to Watch in the Fight Against Breast Cancer in 2020]. P&T Community.
  7. ^ LinkedIn.
  8. ^ Francois Michelon.

External links